MIT robot may accelerate trials for stroke medications
Robot protocol able to cut time and cost of Phase III drug trials by 70 percent.
Robot protocol able to cut time and cost of Phase III drug trials by 70 percent.
In clinical trial, mixture developed at MIT appears to help overcome loss of connections between brain cells.